Abiopharma

🔍 Ericson Brady D (Director)

Company: PHINIA INC. (PHIN)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Sold 31,195 shares of Common Stock at $68.65 per share (Direct)
  Date: 2026-08-28 | Code: F | equity_swap_involved: 0 | shares_owned_after: 358,357.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 940 shares of Common Stock at $68.0321 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 357,417.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 26,920 shares of Common Stock at $68.4065 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 330,497.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Shares automatically and mandatorily withheld to satisfy the tax withholding requirement upon the vesting of restricted stock.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.98 to $68.06, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.125 to $69.06, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F4: Includes 69,122 shares of restricted stock.
• REMARKS: Power of Attorney is attached hereto as Exhibit 24.